Nominee #1 – Neola Medical – Hanna Sjöström, CEO
Tiny lungs, big future. Turning light into life.
Every breath counts, especially when you’ve just taken your first. Preterm born babies struggle with underdeveloped lungs, and current monitoring methods can sometimes detect complications too late.
Neola Medical is advancing neonatal care with a new innovation: a non-invasive medical device that uses advanced laser-based technology to enable continuous lung monitoring and real-time alerts of potentially life-threatening complications. This allows healthcare teams to detect changes earlier and intervene when it matters most – making neonatal care more proactive.
Developed in close collaboration with leading neonatal teams, Neola® is designed for use in Neonatal Intensive Care Units (NICUs) around the world. It’s a breakthrough that aims to give preterm born babies a stronger and safer start in life.
Note: Neola Medical is currently in the clinical phase aiming for market approval in the U.S., followed by Europe.
5 quick facts about the innovation
- Built on Sweden’s legacy of medical technology innovation, developed in close collaboration with neonatal units and clinical teams
- Based on advanced laser spectroscopy, measuring critical changes in lung volume and oxygen gas concentration
- Enables real-time, continuous lung monitoring and early detection of potential complications
- Non-invasive and gentle for newborn babies
- Aims to support earlier intervention, improve clinical decision-making, and contribute to healthier outcomes
